Lawood & Co’s Eli Lilly LLY Stock Holding History

Lawood & Co’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$606K	Sell	505 -8	-2%	-$8.17K	0.41%	52
2026 Q1	$472K	Hold	513	–	–	0.44%	58
2025 Q4	$551K	Buy	+513	New	+$491K	0.52%	52

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Lawood & Co's LLY Position: Q2 2026 in Review

Lawood & Co reduced its Eli Lilly (LLY) stake by 1.6% in Q2 2026, selling an estimated $8.17K and leaving 505 shares worth $606K. The position accounts for 0.41% of the portfolio, ranked #52.

Lawood & Co first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,614 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Lawood & Co held 505 shares of Eli Lilly worth $606K as of Q2 2026.
Lawood & Co sold 8 Eli Lilly shares in Q2 2026, an estimated $8.17K.
Eli Lilly made up 0.41% of Lawood & Co's portfolio in Q2 2026, its #52 holding.
Lawood & Co first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
4,614 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Lawood & Co's 13F filing for Q2 2026, filed 13 Jul 2026.